Held on 05 February 2018
Aspira Pathlab & Diagnostics announced that the Board of Directors of the Company at their meeting held on 05 February 2018, inter alia, has discussed & approved the following matters -- Voluntary delisting of shares from Metropolitan Stock Exchange of India and Calcutta Stock Exchange.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
